Our President and Managing Director, Ms. Jennifer Che, gave a talk at the LSPN Spring 2024 at Boston about strategies for protecting therapeutics in China, touching upon topics like PTE, patent linkage, data exclusivity, how to deal with IP arising in China, and a very interesting recent case in China about semaglutide (Ozempic/Wegovy) that highlighted the nuanced differences in what kind of post filing data can be accepted by the China patent office.

Jennifer enjoyed “talking shop” with so many different patent attorneys from all over bringing their own diverse perspectives, with all the connections made at such a great conference.